Monod Bio

About:

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.

Top Investors: Cercano Management, Matrix Capital Management, Boom Capital Ventures, Pack Ventures, Sahsen Ventures

Description:

Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid, sensitive, and inexpensive analytical assays. Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.

Total Funding Amount:

$25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2021-11-01

Founders:

Alfredo Quijano Rubio, Daniel Adriano Silva Manzano, David Baker, David Shoultz

Number of Employees:

11-50

Last Funding Date:

2022-08-15

IPO Status:

Private

Industries: